Last reviewed · How we verify
NCT05083650
Large Macular Hole Closure Rate With Amniotic Membrane Graft With and Without Limitorrhexis
NA trial testing Macular hole closure with amniotic membrane with/without internal limiting membrane peeling in Macular Holes in 16 participants. Status unknown.
10 December 2022
Quick facts
| Lead sponsor | Instituto de Oftalmología Fundación Conde de Valenciana |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 16 |
| Start date | 10 March 2021 |
| Primary completion | 10 December 2022 |
| Estimated completion | 10 March 2023 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Macular hole closure with amniotic membrane with/without internal limiting membrane peeling
Conditions studied
- Macular Holes — all drugs for Macular Holes →
Sponsor
Instituto de Oftalmología Fundación Conde de Valenciana — full company profile →
Who can join
Adults 40 to 90, any sex, with Macular Holes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with idiopathic macular holes (MHs) postoperative closure rates for large MHs (diameter \> 550 μm) are disappointing and often require a second intervention, different techniques have been described with very variable success rates in different published studies, an efficient technique with good functional outcome has not been found.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05083650
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Macular Holes
Currently open trials in the same condition.
- NCT06211907 — Small Macular Holes Treated With Air · NA · recruiting
- NCT06000111 — Duration of Face Down Positioning for Full-Thickness Macular Hole Repair · NA · recruiting
- NCT04904679 — The Use of Amniotic Membrane or Internal Limiting Membrane for Large or Refractory Macular Holes: A Prospective Study · NA · active not recruiting
- NCT03713268 — Intraoperative OCT Guidance of Intraocular Surgery II · recruiting
Other Instituto de Oftalmología Fundación Conde de Valenciana trials
Trials by the same sponsor.
- NCT07372014 — A Comparative Analysis of the Effectiveness of Nepafenac Combined With a Lubricant Versus a Lubricant Alone in the Treat · Phase 4 · active not recruiting
- NCT07385495 — OJO-miR: microRNA Expression in Allergic Conjunctivitis. · active not recruiting
- NCT07376148 — Fractional CO2 Laser-assisted Delivery of Hyaluronic Acid, Ascorbic Acid and Sodium DNA For Enhancing Facial Skin Qualit · Phase 4 · recruiting
- NCT07387536 — The Effectiveness of Topical Silicone Application Combined With Photoprotection in the Development of Scarring Following · Phase 4 · recruiting
- NCT07372911 — PRoTECT: Corneal Wavefront Guided PRK + Epi-off CXL vs. PTK+Epi-off CXL in Keratoconus · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05083650 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto de Oftalmología Fundación Conde de Valenciana
- Last refreshed: 19 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05083650.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing